Gilead Sciences Financial Market Data
| Last Close 30-Sep-2008 |
$45.63 |
Price/ Sales Ratio |
9.11 |
| 52-Week High |
$57.63 |
Price/ Book Ratio |
11.33 |
| 52-Week Low |
$39.80 |
Price/ Earnings Ratio |
24.84 |
| 60-Month Beta |
0.8 |
Price/ Cash Flow Ratio |
24.19 |
| Market Cap (mil.) |
$42,099.1 |
Return on Assets |
30.7% |
| Shares Outstanding (mil.) |
922.6 |
Return on Equity |
55.5% |
| Dividend Rate |
-- |
Current Ratio |
1.50 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.38 |
| # of Institutional Holders |
845 |
% Owned by Institutions |
91.0% |
| Latest Short Interest Ratio |
2.20 |
Latest Net Insider Transactions |
0.00 |
| Revenue Growth |
25.9% |
189.2% |
586.7% |
| EPS Growth |
0.0% |
189.9% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |

This data is provided as per license from EDGAR Online